Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the study drug is safe, tolerable and active in
reducing fluid overload/weight gain between dialysis sessions for patients with End Stage
Renal Disease on Hemodialysis.